Skip to content
Abstract
Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review
Related reading
-
Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.
Cureus • April 1, 2025 • via PubMed
-
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Expert Review of Clinical Pharmacology • August 13, 2018 • via OpenAlex
-
THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS
International Journal of Innovative Technologies in Social Science • January 23, 2026 • via OpenAlex
-
Exploring the Effects of Psilocybin on Depression and the Mediating Role of the 5-HT2A Receptor: A Systematic Review
Acta Neuropsychiatrica • September 3, 2025 • via OpenAlex
-
Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials
June 20, 2024 • via OpenAlex